Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
They also had shelf placement 3 days ago.
Trade nimbly....an offering is likely soon due to their dicey cash/debt situation.
News: $EYEG EyeGate Pharma Hits Primary Endpoint in PRK Pivotal Study
WALTHAM, MA / ACCESSWIRE / November 22, 2019 / EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage company focused on developing products for treating disorders of the eye, announced today that it has received select topline data, specifically the prima...
Find out more EYEG - EyeGate Pharma Hits Primary Endpoint in PRK Pivotal Study
Rally continuesss ..Phase 3 results imminent which could push this extreme low float gem to $10 and higher
EYEG =Mkt-Cap $14 M--Shares Out only 3.6 M--Unique OBG eye drops final P3 readout imminent= 10 Bagger potential
"We are on track to receive topline results for the corneal wound healing pivotal study before the end of 2019 and continue to enroll for the follow-on pilot study in patients with punctate epitheliopathies ("PE").
Will hit $10 very quickly with good results
MARKET CAP LAUGHABLE $13 MILLION + EXTREME LOW FLOAT OF 700K SHARES + PHASE 3 RESULTS IMMINENT (during Q4)= NUCLEAR BOMB
News: $EYEG EyeGate Pharma Regains Nasdaq Listing Compliance
WALTHAM, MA / ACCESSWIRE / September 23, 2019 / EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage company focused on developing products for treating disorders of the eye, announced today that the Company has regained compliance with Nasdaq Listing Ru...
Got this from EYEG - EyeGate Pharma Regains Nasdaq Listing Compliance
News: $EYEG EyeGate Pharma Receives Approval from FDA to Initiate PE Pilot Study
WALTHAM, MA / ACCESSWIRE / August 5, 2019 / EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG ) (“EyeGate” or “the Company”), a clinical-stage company focused on developing products for treating disorders of the eye, announced today that it has received approval from th...
Got this from EyeGate Pharma Receives Approval from FDA to Initiate PE Pilot Study
* * $EYEG Video Chart 06-03-2019 * *
Link to Video - click here to watch the technical chart video
News: $EYEG EyeGate Receives Approval from FDA to Initiate PRK Pivotal Study
WALTHAM, MA / ACCESSWIRE / June 3, 2019 / EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) ("EyeGate" or "the Company") announced today it has received approval from the U.S. Food and Drug Administration ("FDA") to initiate its photorefractive keratectomy ("PRK") pivotal study. The FDA has deter...
Find out more https://marketwirenews.com/news-releases/eyegate-receives-approval-from-fda-to-initiate-prk-pivotal-study-8287582.html
* * $EYEG Video Chart 05-30-2019 * *
Link to Video - click here to watch the technical chart video
They're trying to suck in buyers before they execute a reverse split, coming soon.
UFO
wow we are moving today!!!!
News: $EYEG EyeGate Pharma Reports First Quarter 2019 Financial Results and Provides Business Update
WALTHAM, MA / ACCESSWIRE / May 8, 2019 / EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) ("EyeGate" or "the Company") today announced financial results for the quarter ended March 31, 2019 and provided an update on recent corporate and operational activities. Stephen From, EyeGate's Chief Exec...
Read the whole news https://marketwirenews.com/news-releases/eyegate-pharma-reports-first-quarter-2019-financial-results-and-provides-business-update-8146244.html
we hit the low today for now.
Still waiting, maybe under 0,30 again. But definitely turning again imo
added mucho amount today.....
A buy again imo in the mid 0,30´s!
Still on watch. Chart is bottomed out. This is one of around 20 on my WL, not possible to gain on all of them...
not so much, eh? headin in the wrongo direction. crazy trade at EOD today.
Looks like it´s going to see 0,60 again this week. Has been a nice swing trade for several times already
this was over 20 at one point, no?
Bullish chart to finally break that resistance in the 0,60´s...
Have been reading the whole ER and did some additional DD:
- reduced liabilities
- increased revenues
- positive top line results from 2 products today
- additional 180 days for Nasdaq compliance until 3/18/2019
- enough cash for operational costs and research until September 2019
- OS 43,3 million
- went public in 2015 and did exactly 2 public offering (June '17 and April '18)
- biggest volume in history today (which may have eaten up a big chunk of the float and even enlarged the short position in here regarding todays price action...)
Good figures compared to the last ER's and great updates about their products...
* * $EYEG Video Chart 11-13-18 * *
Link to Video - click here to watch the technical chart video
Took off the table as high as .635. If it were to push higher I will continue to sell. If it drops back under .40 I would buy. All plain and simple.
There were also 200K to 500K block trades much higher than that. Watch for EYEG to break .60 then she heads back to a dollar.
200k flashed on the bid at .49 a few minutes ago. somebody wants in
15 million shares traded during 1,5 hours building a very nice chart setup above 0,50!
Watch for EYEG to break .60 then look at that $1.20 on the chart above. 2 great PR's this AM. This one deserves to be back in dollars ahead.
EYEG should break .60 soon then the real fun above begins.
Jep, but the question is what might be the float?!? Gets eaten up anyways, breakout above 0,60 into blue skies seems near. Bouncing of former resistance @0,50. About to break 52-week record volume!
43 mill outstanding as updated a week ago.
Followers
|
26
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
418
|
Created
|
07/20/15
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |